Synthesis and Structure Activity Relationship Studies of Benzothieno[3,2-b]furan Derivatives as a Novel Class of IKKβ Inhibitors
スポンサーリンク
概要
- 論文の詳細を見る
As a novel class of IKKβ inhibitors, a series of tricyclic furan derivatives was designed and synthesized based on the structure of known thiophene IKKβ inhibitors. Among the various fused furan derivatives synthesized, a benzothieno [3, 2-b] furan derivative 13a displayed potent inhibitory activity towards IKKβ in enzymatic and cellular assays. The potent inhibitory activity originates from an intramolecular non-bonded S・・・O interaction which was confirmed by the X-ray structure of JNK3 with 16k. The introduction of further substituents on the core structure led to the discovery of the 6-alkoxy derivatives, which possessed a comparable IKKβ inhibitory activity to 13a and an improved metabolic stability. Among these, appropriately lipophilic compounds 16a, h, i, and 13g (logD>2) were found to possess good oral bioavailability.
- 社団法人日本薬学会の論文
- 2007-04-01
著者
-
Kimura Hiroyuki
Pharmaceutical Research Division Takeda Pharmaceutical Company Limited
-
Tanaka Toshimasa
Pharmaceutical Research Division Takeda Chemical Industries Ltd.
-
Tanaka Toshimasa
Pharmaceutical Research Division Discovery Research Center Takeda Pharmaceutical Company Limited
-
Tanaka Toshimasa
Pharmaceutical Research Division Takeda Pharmaceutical Company Limited
-
SUGIYAMA Hideyuki
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited
-
YOSHIDA Masato
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited
-
MORI Kouji
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited
-
KAWAMOTO Tomohiro
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited
-
SOGABE Satoshi
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited
-
TAKAGI Terufumi
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited
-
OKI Hideyuki
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited
-
IKEURA Yoshinori
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited
-
Kimura Hiroyuki
Pharmaceutical Res. Div. Takeda Pharmaceutical Co. Ltd.
-
Mori Kouji
Pharmaceutical Research Division Takeda Pharmaceutical Company Limited
-
Oki Hideyuki
Pharmaceutical Research Division Takeda Pharmaceutical Company Limited
-
Sogabe Satoshi
Pharmaceutical Research Division Takeda Pharmaceutical Company Limited
-
Takagi Terufumi
Pharmaceutical Research Division Takeda Pharmaceutical Company Limited
-
Ikeura Yoshinori
Pharmaceutical Research Division Takeda Pharmaceutical Company Limited
-
Ikeura Yoshinori
Pharmaceutical Research Division Takeda Chemical Industries Ltd.
-
Kawamoto Tomohiro
Pharmaceutical Res. Div. Takeda Pharmaceutical Co. Ltd.
-
Kawamoto Tomohiro
Pharmaceutical Research Division Takeda Pharmaceutical Company Limited
-
Sugiyama Hideyuki
Pharmaceutical Research Division Takeda Pharmaceutical Company Limited
-
Yoshida Masato
Pharmaceutical Research Division Takeda Pharmaceutical Company Limited
関連論文
- OE-020 Molecular and Structural Basis for Mechanical Stress-induced Activation of AT Receptor(Cardiovascular pharmacology, basic/clinical(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- Synthesis and Structure Activity Relationship Studies of Benzothieno[3,2-b]furan Derivatives as a Novel Class of IKKβ Inhibitors
- Synthesis and Biological Activities of 4-Phenyl-5-pyridyl-1, 3-thiazole Derivatives as p38 MAP Kinase Inhibitors
- Potent NK_1 Receptor Antagonists : Synthesis and Antagonistic Activity of Various Heterocycles with an N-[3,5-Bis(trifluoromethyl)benzyl]-N-methylcarbamoyl Substituent
- Characterization of the CYP2C8 Active Site by Homology Modeling
- Characterization of the CYP3A4 Active Site by Homology Modeling
- Microbial Synthesis of Three Metabolites of a Tachykinin Receptor Antagonist, TAK-637
- Synthesis of (-)-Epibatidine and Its Derivatives from Chiral Allene-1,3-dicarboxylate Esters